Aberdeen Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$146M Buy
2,057,324
+175,102
+9% +$11.7M 0.49% 41
2017
Q1
$128M Buy
1,882,222
+475,086
+34% +$33.4M 0.45% 43
2016
Q4
$101M Sell
1,407,136
-11,188
-0.8% -$832K 0.39% 49
2016
Q3
$112M Buy
1,418,324
+16,848
+1% +$1.37M 0.4% 46
2016
Q2
$117M Sell
1,401,476
-17,922
-1% -$1.59M 0.43% 43
2016
Q1
$130M Sell
1,419,398
-57,002
-4% -$5.14M 0.47% 38
2015
Q4
$159M Sell
1,476,400
-58,723
-4% -$6.11M 0.54% 34
2015
Q3
$151M Sell
1,535,123
-93,431
-6% -$10.4M 0.51% 35
2015
Q2
$191M Sell
1,628,554
-14,946
-0.9% -$1.63M 0.55% 31
2015
Q1
$161M Buy
1,643,500
+115,612
+8% +$11.7M 0.43% 34
2014
Q4
$144M Sell
1,527,888
-236,342
-13% -$24.4M 0.36% 39
2014
Q3
$188M Sell
1,764,230
-149,675
-8% -$14.7M 0.41% 35
2014
Q2
$159M Buy
1,913,905
+852,283
+80% +$66.3M 0.33% 41
2014
Q1
$72.4M Buy
1,061,622
+121,700
+13% +$9.54M 0.2% 50
2013
Q4
$67.9M Sell
939,922
-14,500
-2% -$1.01M 0.19% 53
2013
Q3
$58.9M Buy
954,422
+237,014
+33% +$14.2M 0.17% 55
2013
Q2
$36.8M Buy
+717,408
New +$37.4M 0.12% 60

Other funds holding GILD

Aberdeen Asset Management's GILD Position: Q2 2017 in Review

Aberdeen Asset Management increased its Gilead Sciences (GILD) stake by 9.3% in Q2 2017, buying an estimated $11.7M and bringing the position to 2,057,324 shares worth $146M. The position accounts for 0.49% of the portfolio, ranked #41.

Aberdeen Asset Management first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. The position peaked at $191M in Q2 2015. 1,520 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Aberdeen Asset Management held 2,057,324 shares of Gilead Sciences worth $146M as of Q2 2017.
  • Aberdeen Asset Management bought 175,102 Gilead Sciences shares in Q2 2017, an estimated $11.7M.
  • Gilead Sciences made up 0.49% of Aberdeen Asset Management's portfolio in Q2 2017, its #41 holding.
  • Aberdeen Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • Aberdeen Asset Management's Gilead Sciences position peaked at $191M in Q2 2015.
  • 1,520 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.